全踝关节置换与踝关节融合术后4年患者报告结局变化比较
这项多中心前瞻性队列研究纳入517例终末期踝关节炎手术患者(TAA 414例、AA 103例),比较术后48个月FAAM、SF-36及疼痛评分变化。两组均在48个月时显著改善,TAA组功能改善幅度高于AA组,且24个月时的改善在48个月时得以维持。
要点
- TAA与AA术后48个月整体功能、踝特异性功能及疼痛均显著改善。
- TAA组FAAM日常生活、FAAM运动及SF-36改善幅度高于AA组。
- TAA组最痛与平均疼痛改善在12、24、36个月时至少高0.9分,48个月时差异减弱。
核心结论
- 由同一组外科医生实施手术时,TAA或AA治疗终末期踝关节炎在术后48个月均显著改善整体功能、踝特异性功能和疼痛,TAA组功能改善更佳。
研究设计与样本
- 多中心前瞻性队列研究,纳入517例受试者(TAA 414例、AA 103例),术后48个月比较FAAM日常生活与运动子量表(0至100分)、SF-36 PCS与MCS(0至100分)及疼痛评分(0至10分)。
主要发现
- 两组在术后48个月时2项FAAM指标、SF-36 PCS及所有疼痛指标均较基线显著改善(p < 0.001)。
- TAA组FAAM日常生活、FAAM运动和SF-36评分较基线的平均改善分别至少9分、8分和3.5分,高于AA组。
- TAA组最痛和平均疼痛的平均改善在12、24、36个月时至少比AA组高0.9分,48个月时这些差异减弱。
- 两种治疗从基线至24个月的所有改善在48个月时均得以维持。
关键数值与推荐
- FAAM日常生活与运动子量表评分范围0至100分,SF-36 PCS与MCS评分范围0至100分,疼痛评分范围0至10分。
- 证据等级为治疗性II级。
临床怎么用
- 向终末期踝关节炎患者咨询时,可说明TAA与AA在48个月时均有显著功能与疼痛改善,TAA组功能改善幅度更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The rate of total ankle arthroplasty (TAA) is increasing relative to ankle arthrodesis (AA) for patients seeking surgical treatment for end-stage ankle arthritis. Patients and providers would benefit from a more complete understanding of the rate of improvement, the average length of time to achieve maximal function and minimal pain, and whether there is a greater decline in function or an increase in pain over time following TAA compared with AA. The objectives of this study were to compare treatment changes in overall physical and mental function and ankle-specific function, as well as pain intensity at 48 months after TAA or AA in order to determine if the improvements are sustained. METHODS: This was a multisite prospective cohort study that included 517 participants (414 TAA and 103 AA) who presented for surgical treatment. Participants were compared 48 months after surgery using the Foot and Ankle Ability Measure (FAAM) Activities of Daily Living and Sports subscales (0 to 100 points), the Short Form-36 (SF-36) Physical and Mental Component Summary (PCS and MCS) scores (0 to 100 points), and pain scores (0 to 10 points). RESULTS: Both groups achieved significant improvement in the 2 FAAM measures, the SF-36 PCS score, and all of the pain measures at 48 months after surgey (p < 0.001). Mean improvements from baseline in patients undergoing TAA for the FAAM Activities of Daily Living, FAAM Sports, and SF-36 scores were at least 9 points, 8 points, and 3.5 points, respectively, which were higher than in those undergoing AA. Mean improvements in worst and average pain were at least 0.9 point higher in patients undergoing TAA than in those undergoing AA at 12, 24, and 36 months. These differences were attenuated by 48 months. For both treatments, all improvements from baseline to 24 months had been maintained at 48 months. CONCLUSIONS: When both procedures are performed by the same group of surgeons, patients who undergo TAA or AA for end-stage ankle arthritis have significant improvement in overall function, ankle-specific function, and pain at 48 months after surgery, with better functional improvement in the TAA group. LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
引用
- Sangeorzan BJ, Ledoux WR, Shofer JB, et al. Comparing 4-Year Changes in Patient-Reported Outcomes Following Ankle Arthroplasty and Arthrodesis. J Bone Joint Surg Am. 2021. PMID: 33983146. doi:10.2106/JBJS.20.01357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。